CSIMarket
 


Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 

Zimmer Biomet Holdings Inc 's Working Capital Ratio

ZBH's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Current Liabilities decreased faster than Zimmer Biomet Holdings Inc 's Current Assets, this led to improvement in Zimmer Biomet Holdings Inc 's Working Capital Ratio to 2.11, above Zimmer Biomet Holdings Inc average Working Capital Ratio.

Within Medical Equipment & Supplies industry 146 other companies have achieved higher Working Capital Ratio than Zimmer Biomet Holdings Inc in third quarter 2023. While Working Capital Ratio total ranking has improved so far during the III Quarter 2023 to 2182, from total ranking in the second quarter 2023 at 2454.

Explain Working Capital Ratio
How much in Current Assets ZBH´s has?
What is the value of ZBH´s Current Liabilities?


ZBH Working Capital Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change -9.77 % -9.33 % -12.65 % -32 % -21.89 %
Y / Y Current Assets Change -3.58 % -1.68 % -2.32 % -9.37 % -14.64 %
Working Capital Ratio MRQ 2.11 1.96 1.89 1.88 1.98
ZBH's Total Ranking # 2182 # 2454 # 2657 # 2926 # 3041
Seq. Current Liabilities Change -7.26 % -4.38 % -0.95 % 2.72 % -6.82 %
Seq. Current Assets Change -0.36 % -0.54 % -0.35 % -2.36 % 1.6 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 147
Healthcare Sector # 734
Overall Market # 2180


Working Capital Ratio Statistics
High Average Low
4.07 2.1 1.17
(Dec 31 2013)   (Sep 30 2019)




Financial Statements
Zimmer Biomet Holdings Inc 's Current Liabilities $ 2,072 Millions Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Current Assets $ 4,372 Millions Visit ZBH's Balance sheet
Source of ZBH's Sales Visit ZBH's Sales by Geography


Cumulative Zimmer Biomet Holdings Inc 's Working Capital Ratio

ZBH's Working Capital Ratio for the trailling 12 Months

ZBH Working Capital Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth -9.77 % -9.33 % -12.65 % -32 % -21.89 %
Y / Y Current Assets TTM Growth -3.58 % -1.68 % -2.32 % -9.37 % -14.64 %
Working Capital Ratio TTM 1.96 1.93 1.89 1.83 1.69
Total Ranking TTM # 3901 # 4087 # 1206 # 1174 # 2371
Seq. Current Liabilities TTM Growth -7.26 % -4.38 % -0.95 % 2.72 % -6.82 %
Seq. Current Assets TTM Growth -0.36 % -0.54 % -0.35 % -2.36 % 1.6 %


On the trailing twelve months basis Current Liabilities decreased faster than Zimmer Biomet Holdings Inc 's average Current Assets, this led to increase in in Zimmer Biomet Holdings Inc 's Working Capital Ratio to 1.96, above ZBH average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 223 other companies have achieved higher Working Capital Ratio than Zimmer Biomet Holdings Inc . While Working Capital Ratio overall ranking has improved so far to 3901, from total ranking during the twelve months ending second quarter 2023 at 4087.

Explain Working Capital Ratio
How much in Current Assets ZBH´s has?
What is the value of ZBH´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 224
Healthcare Sector # 1011
Within the Market # 3901


trailing twelve months Working Capital Ratio Statistics
High Average Low
2.2 1.76 1.36
(Mar 31 2021)   (Mar 31 2020)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Working Capital RatioSep 30 2023 MRQ Current AssetsSep 30 2023 MRQ Current Liabilities
Treace Medical Concepts Inc   5.64 $ 187.142  Millions$ 33.154  Millions
Nephros Inc   5.61 $ 8.506  Millions$ 1.517  Millions
Anika Therapeutics Inc   5.59 $ 156.778  Millions$ 28.064  Millions
Lyra Therapeutics Inc   5.45 $ 104.920  Millions$ 19.235  Millions
Tela Bio Inc   5.36 $ 82.252  Millions$ 15.334  Millions
Outset Medical Inc   5.35 $ 283.774  Millions$ 53.024  Millions
Orchestra Biomed Holdings Inc   5.32 $ 110.189  Millions$ 20.726  Millions
Intuitive Surgical Inc   5.31 $ 8,902.900  Millions$ 1,676.400  Millions
Koru Medical Systems Inc  5.14 $ 21.687  Millions$ 4.222  Millions
Star Equity Holdings Inc   5.12 $ 34.613  Millions$ 6.761  Millions
Glucotrack Inc   4.93 $ 7.169  Millions$ 1.454  Millions
Acutus Medical Inc   4.92 $ 72.637  Millions$ 14.767  Millions
Neuronetics inc   4.90 $ 71.011  Millions$ 14.496  Millions
Apyx Medical Corporation  4.87 $ 50.150  Millions$ 10.294  Millions
Artivion Inc   4.86 $ 267.109  Millions$ 54.959  Millions
Orthopediatrics Corp  4.72 $ 226.172  Millions$ 47.927  Millions
Inogen Inc   4.69 $ 225.268  Millions$ 48.009  Millions
Globus Medical Inc   4.47 $ 1,917.337  Millions$ 428.722  Millions
Logicmark Inc   4.45 $ 8.572  Millions$ 1.927  Millions
Lensar Inc   4.42 $ 48.645  Millions$ 11.011  Millions
Carlisle Companies Incorporated  4.30 $ 3,657.000  Millions$ 849.900  Millions
Vivani Medical Inc   4.13 $ 30.682  Millions$ 7.433  Millions
Neuroone Medical Technologies Corporation  4.08 $ 7.313  Millions$ 1.793  Millions
Inovio Pharmaceuticals Inc   4.00 $ 174.767  Millions$ 43.711  Millions
Pro dex Inc   3.79 $ 31.424  Millions$ 8.281  Millions
Asensus Surgical Inc   3.79 $ 45.932  Millions$ 12.123  Millions
Beyond Air Inc   3.78 $ 47.134  Millions$ 12.454  Millions
Establishment Labs Holdings Inc   3.71 $ 186.721  Millions$ 50.302  Millions
West Pharmaceutical Services Inc   3.70 $ 1,972.300  Millions$ 533.500  Millions
Surmodics Inc  3.62 $ 86.691  Millions$ 23.954  Millions

Date modified: 2023-11-08T18:47:34+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com